Kyntra Bio KYNB Revenue Breakdown

NASDAQ KYNB
$3.20 -0.29 (-8.31%)
At close: Nov 16, 2026 · 4:00 PM EST
Annual revenue breakdowns for Kyntra Bio, fiscal 2013 to 2025, as reported in its filings.
Annual history

Kyntra Bio Revenue by Product & Service

Years FY 2016–2025
Lines 2
FY 2025 Total $6.44M

Drug Product Revenue, Net was Kyntra Bio’s largest product and service line in fiscal 2025, bringing in $5.85M of $6.44M (91%).

Kyntra Bio revenue by product and service, fiscal 2016 to 2025
Product and Service FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Development & Other Revenue $24.19M $18.40M $1.95M $592.00K
Drug Product Revenue, Net $11.09M $18.75M $27.67M $5.85M
Total $140.73M $47.30M $29.62M $6.44M
Totals include 4 discontinued lines from earlier reporting.

Kyntra Bio revenue by product and service: what the figures show

Kyntra Bio brought in $6.44M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 78.3% from $29.62M in fiscal 2024. Drug Product Revenue, Net was the largest at $5.85M (90.8%), ahead of Development & Other Revenue at $592.00K (9.2%).

Compared with fiscal 2024, Development & Other Revenue fell 69.6% to $592.00K and Drug Product Revenue, Net fell 78.9% to $5.85M.

Kyntra Bio stopped reporting Product Revenue, Net ($82.87M in fiscal 2022), License Revenue ($9.65M in fiscal 2023) and Other Revenue - Patent Transfer ($500.00K in fiscal 2023) as separate lines.

Annual history

Kyntra Bio Revenue by Geography

Years FY 2013–2025
Lines 2
FY 2025 Total $6.44M

Europe was Kyntra Bio’s largest region in fiscal 2025, bringing in $5.64M of $6.44M (88%).

Kyntra Bio revenue by geography, fiscal 2013 to 2025
Geography FY 2013 FY 2014 FY 2015 FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Europe $33.82M $9.55M $6.27M $5.64M
Japan $9.76M $15.87M -$2.85M $797.00K
Total $140.73M $46.80M $29.62M $6.44M
Totals include 3 discontinued lines from earlier reporting.

Kyntra Bio revenue by geography: what the figures show

Kyntra Bio brought in $6.44M from its two regions in fiscal 2025, the year ended December 31, 2025. Kyntra Bio regrouped these regions after fiscal 2024, so the total does not compare directly with that year's $29.62M. Europe was the largest at $5.64M (87.6%), ahead of Japan at $797.00K (12.4%).

Kyntra Bio stopped reporting U.S ($26.11M in fiscal 2024) and China ($91.00K in fiscal 2024) as separate regions.

Annual history

Kyntra Bio Revenue by SEC Schedule, 12-09, Valuation Allowances & Reserves Type

Years FY 2024–2025
Lines 2
FY 2025 Total $6.45M

Drug Product Revenue, Net was Kyntra Bio’s largest revenue line in fiscal 2025, bringing in $5.85M of $6.45M (91%).

Kyntra Bio revenue by sec schedule, 12-09, valuation allowances and reserves type, fiscal 2024 to 2025
SEC Schedule, 12-09, Valuation Allowances and Reserves Type FY 2024 FY 2025
Drug Product Revenue, Net $27.67M $5.85M
Development Revenue $1.40M $600.00K
Total $29.07M $6.45M

Kyntra Bio revenue by sec schedule, 12-09, valuation allowances and reserves type: what the figures show

Kyntra Bio brought in $6.45M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was down 77.8% from $29.07M in fiscal 2024. Drug Product Revenue, Net was the largest at $5.85M (90.7%), ahead of Development Revenue at $600.00K (9.3%).

Compared with fiscal 2024, Development Revenue fell 57.1% to $600.00K and Drug Product Revenue, Net fell 78.9% to $5.85M.

Questions

Kyntra Bio Revenue Breakdown FAQ

How does Kyntra Bio make money?

Kyntra Bio (KYNB) reports its revenue by product and service, by geography and by sec schedule, 12-09, valuation allowances and reserves type. In fiscal 2025, Drug Product Revenue, Net was its largest product and service line, bringing in $5.85M (90.8% of the total), followed by Development & Other Revenue at $592.00K (9.2%).

What is Kyntra Bio's largest product and service line?

Drug Product Revenue, Net was Kyntra Bio's largest product and service line in fiscal 2025, bringing in $5.85M, or 90.8% of the $6.44M total across its two product and service lines.

What is Kyntra Bio's largest region?

Europe was Kyntra Bio's largest region in fiscal 2025, bringing in $5.64M, or 87.6% of the $6.44M total across its two regions.

What is Kyntra Bio's largest revenue line?

Drug Product Revenue, Net was Kyntra Bio's largest revenue line in fiscal 2025, bringing in $5.85M, or 90.7% of the $6.45M total across its two revenue lines.

Where does this revenue breakdown data come from?

Every figure comes from Kyntra Bio's annual financial filings, as reported. Each line keeps the name Kyntra Bio gives it, and years follow its fiscal calendar.

How far back does Kyntra Bio's revenue breakdown go?

Kyntra Bio's revenue by product and service goes back to fiscal 2016, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.